Imagine one of Denmark's many picturesque beaches, the waves lapping against the shore, the golden sand and the smooth ...

Autolus Therapeutics' obe-cel, branded Aucatzyl, is the first CAR-T therapy approved without a REMS, highlighting its safety and unique mechanism.

The international consulting firm Clarivate makes its bet among the novelties ready for the medicine cabinet this year: three ...

HCW Biologics gets US FDA nod to begin first-in-human phase 1 trial of HCW9302 to treat patients with moderate-to-severe alopecia areata: Miramar, Florida Wednesday, February 5, 2 ...

A research team led by Professor Kazuaki Sawada and Project Assistant Professor Hideo Doi of the Department of Electrical and Electronic Information ...

Antidotes are critical in toxicology, offering therapeutic solutions to poisoning by neutralizing toxins and enhancing the ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of ...

Imfinzi recommended for approval in European Union for the treat of adults with limited-stage small cell lung cancer ...

A few companies are in clinicals with novel approaches to heal an initial brain injury or minimize secondary damage. Slow progress may be more related to investors’ misperceptions of the topic than ...

retriever generates disease-specific transcriptional drug response signatures by merging transcriptional signatures over time, concentration, and cell-type. These signatures can then be matched to ...

International collaborative research led by Aakash Project* researchers at the Research Institute for Humanity and Nature (RIHN) show an unequivocal contribution of crop residue burning (CRB) to air ...